By Karina Daiha Four recently published Guidelines shed light on ANVISA's procedures related to prior approval analysis of patent applications. In November 2020, the Brazilian Health…
by Louis Lozouet In our previous article on May 15, 2020, we discussed the "Brazilian Patent and Trademark Office (BRPTO) Plan To Combat Patent Backlog…
By Louis Lozouet The framework of innovation in Brazil The purpose of this article is to show that tax incentive policies fostering innovation and the…
By Andre Venturini Backlog is the first word that comes to an applicant’s mind when considering Brazil for patent filings. Indeed, at its worst, official…
By Julian Cornelius Over the last years, Brazil has significantly invested in its start-up industry. This can be seen in the creation of incubators, accelerators,…
By Karina Daiha and Andre Venturini In a recent article, we analysed a study by the Brazilian Patent Office (INPI) on the categorization of biotechnology patent…
By Julian Cornelius On 12 February, by Rule235/2019, the INPI (the Brazilian Patent Office) initiated Phase II of the Patent Prosecution Highway (PPH) Pilot Project…
Irisin and the patentability of new methods for treating diseases in Brazil By Karina Daiha New research led by Brazilian scientists has indicated a relationship…